234 related articles for article (PubMed ID: 16964397)
21. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.
Liu LZ; Hu XW; Xia C; He J; Zhou Q; Shi X; Fang J; Jiang BH
Free Radic Biol Med; 2006 Nov; 41(10):1521-33. PubMed ID: 17045920
[TBL] [Abstract][Full Text] [Related]
22. Cimetidine inhibits epidermal growth factor-induced cell signaling.
Fujikawa T; Shiraha H; Nakanishi Y; Takaoka N; Ueda N; Suzuki M; Shiratori Y
J Gastroenterol Hepatol; 2007 Mar; 22(3):436-43. PubMed ID: 17295779
[TBL] [Abstract][Full Text] [Related]
23. E2F3a is critically involved in epidermal growth factor receptor-directed proliferation in ovarian cancer.
Reimer D; Hubalek M; Riedle S; Skvortsov S; Erdel M; Concin N; Fiegl H; Müller-Holzner E; Marth C; Illmensee K; Altevogt P; Zeimet AG
Cancer Res; 2010 Jun; 70(11):4613-23. PubMed ID: 20460525
[TBL] [Abstract][Full Text] [Related]
24. Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation.
Xu J; Zhang QG; Li C; Zhang GY
Hippocampus; 2007; 17(7):525-37. PubMed ID: 17492691
[TBL] [Abstract][Full Text] [Related]
25. Effects of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) on endometrial cancer (HHUA) cell apoptosis and EGF stimulated cell proliferation in vitro.
Mochizuki T; Sakai K; Iwashita M
Growth Horm IGF Res; 2006 Jun; 16(3):202-10. PubMed ID: 16844395
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
Zolfaghari A; Djakiew D
Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
[TBL] [Abstract][Full Text] [Related]
27. BDNF/ TrkB interaction regulates migration of SVZ precursor cells via PI3-K and MAP-K signalling pathways.
Chiaramello S; Dalmasso G; Bezin L; Marcel D; Jourdan F; Peretto P; Fasolo A; De Marchis S
Eur J Neurosci; 2007 Oct; 26(7):1780-90. PubMed ID: 17883412
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
Hua K; Feng W; Cao Q; Zhou X; Lu X; Feng Y
Int J Oncol; 2008 Nov; 33(5):959-67. PubMed ID: 18949358
[TBL] [Abstract][Full Text] [Related]
29. Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility.
Larsen AB; Pedersen MW; Stockhausen MT; Grandal MV; van Deurs B; Poulsen HS
Mol Cancer Res; 2007 Mar; 5(3):283-93. PubMed ID: 17374733
[TBL] [Abstract][Full Text] [Related]
30. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
31. [Study of brain-derived neurotrophic factor activating TrkB signaling cascades in the pathogenesis of multiple myeloma].
Sun CY; Hu Y; Guo T; Huang J; Zhang L; Chu ZB
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):238-42. PubMed ID: 18843977
[TBL] [Abstract][Full Text] [Related]
32. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.
Pillai A; Veeranan-Karmegam R; Dhandapani KM; Mahadik SP
J Neurochem; 2008 Nov; 107(4):941-51. PubMed ID: 18786174
[TBL] [Abstract][Full Text] [Related]
33. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
[TBL] [Abstract][Full Text] [Related]
34. GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells.
Eicke N; Günthert AR; Emons G; Gründker C
Int J Oncol; 2006 Nov; 29(5):1223-9. PubMed ID: 17016655
[TBL] [Abstract][Full Text] [Related]
35. BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition.
de Farias CB; Heinen TE; dos Santos RP; Abujamra AL; Schwartsmann G; Roesler R
Biochem Biophys Res Commun; 2012 Aug; 425(2):328-32. PubMed ID: 22842573
[TBL] [Abstract][Full Text] [Related]
36. Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.
Chan JK; Pham H; You XJ; Cloven NG; Burger RA; Rose GS; Van Nostrand K; Korc M; Disaia PJ; Fan H
Cancer Res; 2005 Apr; 65(8):3243-8. PubMed ID: 15833856
[TBL] [Abstract][Full Text] [Related]
37. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway.
Amorino GP; Deeble PD; Parsons SJ
Oncogene; 2007 Feb; 26(5):745-56. PubMed ID: 16862179
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
[TBL] [Abstract][Full Text] [Related]
39. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
40. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
Kim SH; Song YC; Kim SH; Jo H; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
